elderly patients has risen. Large differences in RRT exist between individual CEE countries and this Background. The epidemiology of end-stage renal disease (ESRD) is changing all over the world. appears mainly dependent on the level of economic development. Particularly dramatic changes of the epidemiology of ESRD have occurred in central and eastern Europe (CEE). The aim of the present study was (i) to Key words: ESRD epidemiology; diabetic nephropathy; central and eastern Europe; renal replacement therapy document the further expansion of renal replacement therapy (RRT ) noted in recent years in CEE and (ii) to analyse in some detail treatment modalities and underlying renal conditions.
Introduction
Methods. Three independent surveys were performed in 1995, 1997 and 1998. Fifteen CEE countries participated. The data were mainly obtained from national Three years ago [1] we reported on the epidemiology registries which are based on centre and patient of end-stage renal disease ( ESRD) and renal replacequestionnaires. ment therapy (RRT ) in countries of central and eastern Results. The data collected from 15 CEE countries Europe (CEE ). The evolution of RRT has recently document further expansion of RRT in this region. gained momentum and notable changes in the composiThe report includes data on the availability of RRT in tion of the patient population and in the use of different Byelorussia, Estonia, and Russia which have become treatment modalities have occurred. available for the first time. The epidemiology of diaIn the past reports have been incomplete to the lysed patients has changed remarkably. In the majority extent that reliable data from Russia had not been of countries the number of diabetic patients has available. increased, most dramatically so in the Czech Republic
The present report gives an update on the epidemi-(31% of all dialysed patients), in the majority of the ology of RRT in the CEE countries, gives for the first other countries 10-14%. The number of ESRD patients time data concerning Russia, and details the epidemiwith the diagnosis of hypertensive nephropathy has ology of some underlying renal diseases. also increased and this was accompanied by an increase in proportion of elderly (>65 years) patients, i.e. 46% in the Czech Republic and 12-25% in most other Subject and methods
countries.
Conclusion. Dramatic changes of the availability of The data are based on three independent surveys performed RRT treatment have occurred in central and eastern in 1995, 1997 and 1998 by the CEE Advisory Board on chronic renal failure. Special questionnaires were filled in by Europe. The proportion of diabetic nephropathy and the members of the board using data from the national registries or collection of information from local renal units.
Correspondence and offprint requests to: Prof. Boleslaw Rutkowski, in addition, national registries or their board members more than 65 years of age increased in all of the four were contacted. Data concerning the period 1990-1992 were countries analysed in this respect despite the different verified using ERA-EDTA Registry reports [6, 7] . The data levels of development of dialysis facilities ( The above data confirm the dramatic development of RRT in CEE. In comparison to our previous report [1] we now include data from Russia and the former Results satellites of the Soviet Union, i.e. Byelorussia and Estonia, which have become available for the first time. In these countries, renal care for ESRD patients The current state of renal replacement therapy in the CEE countries is given in Table 1 .
is still problematic, although it is of note that within Russia the availability of RRT is not uniform. In the In the 14 countries (excluding Russia) 38 860 patients were on RRT at the end of 1998, i.e. 293 pmp. Of regions of Moscow and St. Petersburg, respectively, the availability of dialysis and renal transplantation is these 78% were treated with different modalities of dialysis and 22% lived with a functioning graft. If satisfactory, but in rural areas the chances of a patient with ESRD to obtain access to any type of RRT are Russia was included, the respective figures would be 46 759 patients and 166 pmp respectively.
poor. On the other hand, substantial progress has been achieved within the space of a few years in the Baltic The proportion of transplanted patients differs between countries. The percentage is lowest in countries, i.e. Estonia, Latvija and Lithuania as well as in Romania and Poland [8, 9] . Slovakia, Bulgaria and Yugoslavia, intermediate in Russia, Croatia, Byelorussia or Macedonia, good in
It is striking that in many countries, e.g. Slovakia, Bulgaria, Romania, Yugoslavia, Slovenia or the Czech Republic, Hungary and Poland and best in the Baltic countries ( Estonia, Latvija, Lithuania).
Macedonia, renal transplantation is still neglected, although in the long run this treatment modality is In the CEE countries the average incidence of patients admitted for RRT was 77 pmp, but in nearly much cheaper than any form of dialysis -a point of note in this economically underdeveloped part of the half the countries it exceeded 100 pmp. Although progress has been achieved in the past few years in world. This is the first report giving information on the many countries, a very low incidence, i.e. number of patients admitted, is still seen in Byelorussia, Romania incidence, i.e. patients admitted with end-stage renal failure, in the CEE region. The average incidence (72 and Russia. More than 10% of the dialysed patients were treated using peritoneal dialysis, but striking pmp) is far lower than figures reported from Japan [10] , the United States [11] or Germany [12], but it is differences between countries were seen, the proportions ranging from 1% in Macedonia to 49% in Estonia. close to the figures reported from Australia and New Zealand [13] or Great Britain [14] . In six countries of Nearly half of the dialysed patients were treated with erythropoetin, but large differences between coun-the CEE region, the incidence was above 100 pmp and in a further six countries it was above 50 pmp. tries were observed, e.g. 15-20% in Yugoslavia and Russia, 30-49% in Romania, Estonia, Croatia, 60-70%
In the majority of the countries peritoneal dialysis as a treatment modality has become available only in the Czech Republic, Latvija and Poland, 70-90% in Hungary and Lithuania. The proportions of patients during the last few years. For example, in Macedonia the first CAPD treatment of young children was perreceiving EPO showed some correlation to the Gross National Product per capita.
formed in 1997. Actually, in the region no less than 10% of ESRD patients are treated using this modality. During the last 8 years an increasing number of diabetic patients admitted for RRT was noted in three The development of CAPD was particularly dramatic in the Baltic countries, and in Romania and Poland of the four countries which were analysed in this respect, i.e. Byelorussia, the Czech Republic and [15] . On the other hand, the use of this method decreased during the last 3 years in Hungary and in Poland, but not in Croatia where the proportion of diabetic patients was stable at 10-12%, although this Slovakia, possibly reflecting a negative impact of privatization in the dialysis sector in these countries. country has very good dialysis facilities ( Figure 1a ).
An increasing number of patients diagnosed as Erythropoetin is important for the outcome and quality of life in dialysed patients. This medication is having hypertensive nephropathy was noted in Byelorussia and Poland. In contrast, in the Czech available for nearly half of the ESRD patients in the CEE region [16 ] , the availability of erythropoetin is Republic the number of patients with this diagnosis decreased and it was stable in Croatia ( Figure 1b) . less in CEE countries with less developed economies. A burning issue is how countries of the CEE region There was a remarkable change in the average age of dialysed patients. The number of patients who were which have RRT programmes in the stage of develop- 
NA, not available; *data available from 1997; in brackets, cumulative data including Russia; DT, dialysis therapy; RT, renal transplantation; HD, haemodialysis; PD, peritoneal dialysis; GNP, Gross National Product.
suffer from type II diabetes and 58% of them are older than 50 years [4] . In Poland the absolute number of diabetic patients on dialysis increased by a factor of 4 during the past 6 years [22] . Currently close to 12% of all patients on maintenance haemodialysis have diabetes and diabetic patients account for 17% of newly accepted patients [5] . The ratio of type 1 and type 2 diabetes is 151. Even in countries with lower rates of acceptance, e.g. Byelorussia or Romania, a sharp increase has been noted. It remains to be examined why in some countries with well-developed RRT systems, e.g. Croatia, Yugoslavia, Slovenia, Macedonia, Slovakia and Hungary, the proportion of diabetic patients amongst the dialysed patients has remained relatively stable in the past few years. This is particularly remarkable, since the number of diabetic patients in these regions is increasing [19] . The number of patients admitted with the diagnosis of hypertensive nephropathy is also increasing in some but not all countries in the CEE region. We are aware of the potential pitfalls of this diagnosis. It is remarkable that in countries with welldeveloped renal services, e.g. the Czech Republic or Croatia, only 3-4% of the dialysed patients were diagnosed as having hypertensive nephropathy. In the majority of Western European countries approximately 27-28% of dialysed patients are diagnosed as having hypertensive nephropathy.
In parallel with observations in Western Europe [23] 65 years and nearly 60% above 60 years [4] . The figures may be artifactually high, however, because of the high transplantation activity in the Czech Republic, ment will be able to cope with the rising number of since young patients are transplanted preferentially. patients with diabetes and hypertensive nephropathy To a lesser extent, however, an increase of elderly [17] [18] [19] [20] [21] . As illustrated in Figure 1 , despite differing patients is seen throughout the CEE region. levels of RRT availability, the number of patients with
The above results document that the dramatic devel-ESRD and diabetes as a co-morbid condition is still opment in the somewhat heterogeneous CEE countries increasing in the majority of CEE countries. Such replicates to differing degrees the epidemiological increase was most dramatic in the Czech Republic development which has been noted in Western Europe where diabetic patients currently account for 31% of patients on dialysis. The majority of these patients and in the USA. The above countries were selected as examples of four different levels of dialysis availability: Poor in Byelorussia, Intermediate in Poland, Good in the Czech Republic, and Very good in Croatia.
